BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34022731)

  • 1. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
    Cabel L; Bonneau C; Bernard-Tessier A; Héquet D; Tran-Perennou C; Bataillon G; Rouzier R; Féron JG; Fourchotte V; Le Brun JF; Benoît C; Rodrigues M; Scher N; Minsat M; Legrier ME; Bièche I; Proudhon C; Sastre-Garau X; Bidard FC; Jeannot E
    ESMO Open; 2021 Jun; 6(3):100154. PubMed ID: 34022731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
    Jeannot E; Latouche A; Bonneau C; Calméjane MA; Beaufort C; Ruigrok-Ritstier K; Bataillon G; Larbi Chérif L; Dupain C; Lecerf C; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Jordanova ES; von der Leyen H; Tran-Perennou C; Legrier ME; Dureau S; Raizonville L; Bello Roufai D; Le Tourneau C; Bièche I; Rouzier R; Berns EMJJ; Kamal M; Scholl S
    Clin Cancer Res; 2021 Nov; 27(21):5869-5877. PubMed ID: 34210686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
    Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
    Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
    Han K; Zou J; Zhao Z; Baskurt Z; Zheng Y; Barnes E; Croke J; Ferguson SE; Fyles A; Gien L; Gladwish A; Lecavalier-Barsoum M; Lheureux S; Lukovic J; Mackay H; Marchand EL; Metser U; Milosevic M; Taggar AS; Bratman SV; Leung E
    J Clin Oncol; 2024 Feb; 42(4):431-440. PubMed ID: 37972346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
    Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP
    Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
    Leung E; Han K; Zou J; Zhao Z; Zheng Y; Wang TT; Rostami A; Siu LL; Pugh TJ; Bratman SV
    Clin Cancer Res; 2021 Nov; 27(21):5857-5868. PubMed ID: 34580115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
    Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
    Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
    Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial.
    Bernard-Tessier A; Jeannot E; Guenat D; Debernardi A; Michel M; Proudhon C; Vincent-Salomon A; Bièche I; Pierga JY; Buecher B; Meurisse A; François É; Cohen R; Jary M; Vendrely V; Samalin E; El Hajbi F; Baba-Hamed N; Borg C; Bidard FC; Kim S
    Clin Cancer Res; 2019 Apr; 25(7):2109-2115. PubMed ID: 30504426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer.
    Sivars L; Hellman K; Crona Guterstam Y; Holzhauser S; Nordenskjöld M; Falconer H; Palsdottir K; Tham E
    Gynecol Oncol; 2022 Oct; 167(1):107-114. PubMed ID: 35918201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer.
    Khakoo S; Carter PD; Brown G; Valeri N; Picchia S; Bali MA; Shaikh R; Jones T; Begum R; Rana I; Wotherspoon A; Terlizzo M; von Loga K; Kalaitzaki E; Saffery C; Watkins D; Tait D; Chau I; Starling N; Hubank M; Cunningham D
    Clin Cancer Res; 2020 Jan; 26(1):183-192. PubMed ID: 31852830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma.
    Wang X; Yu N; Cheng G; Zhang T; Wang J; Deng L; Li J; Zhao X; Xu Y; Yang P; Bai N; Li Y; Bi N
    Clin Transl Med; 2022 Nov; 12(11):e1116. PubMed ID: 36437506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
    Campitelli M; Jeannot E; Peter M; Lappartient E; Saada S; de la Rochefordière A; Fourchotte V; Alran S; Petrow P; Cottu P; Pierga JY; Lantz O; Couturier J; Sastre-Garau X
    PLoS One; 2012; 7(8):e43393. PubMed ID: 22937045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.
    Bønløkke S; Stougaard M; Sorensen BS; Booth BB; Høgdall E; Nyvang GB; Lindegaard JC; Blaakær J; Bertelsen J; Fuglsang K; Strube ML; Lenz S; Steiniche T
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
    Turco LC; Pedone Anchora L; Fedele C; Inzani F; Piermattei A; Martini M; Volpe M; Marchetti S; Santangelo R; Bizzarri N; Cosentino F; Vargiu V; De Ninno M; Macchia G; Valentini V; Zannoni G; Scambia G; Ferrandina G
    Int J Gynecol Cancer; 2023 Apr; 33(4):489-497. PubMed ID: 36720505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration Pattern of Human Papillomavirus Is a Strong Prognostic Factor for Disease-Free Survival After Radiation Therapy in Cervical Cancer Patients.
    Joo J; Shin HJ; Park B; Park SY; Yoo CW; Yoon KA; Kong SY; Kim YJ; Kim SS; Kim JY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):654-661. PubMed ID: 28581408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.